Abstract
Fifty invasive ductal carcinomas of the breast were analyzed by immunohistochemistry, polymerase chain reaction‐single strand conformationl polymorphism (PCR‐SSCP) and direct sequencing after microdissection of conventional formalin‐fixed, paraffin‐embedded tissues. A highly significant association between the presence of p53 gene mutation and nuclear accumulation of p53 protein was found (P< 0,0001). Of 13 tumors that demonstrated p53 gene mutations, 11 (84.6%) showed nuclear accumulation of p53 protein. However, of 37 tumors in which gene mutations were not detected, only 5 (13.5%) showed nuclear accumulation of p53 protein. There was a statistically significant association between the nuclear accumulation of p53 protein and a higher histological grade (P< 0.001) or mitotic index (P<0.01). In addition, gene mutations had a statistically significant association with a higher histological grade (P<0.05) or mitotic index (P> 0.0001). Therefore, p53 abnormalities might be associated with an aggressive phenotype in breast cancer. We conclude that the immunohistochem‐ical detection of nuclear p53 protein accumulation is highly associated with p53 gene mutations in archival paraffin‐embedded tissues, and that this method is useful for rapid screening of p53 abnormalities.
Keywords: Breast cancer, p53, Gene mutation, Immunohistochemistry
Full Text
The Full Text of this article is available as a PDF (449.1 KB).
REFERENCES
- 1. ) Bartek , J. , Bartkova , J. , Vojtesek , B. , Staskova , Z. , Rejthar , A. , Kovarik , J. and Lane , D. P.Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro . Int. J. Cancer , 46 , 839 – 844 ( 1990. ). [DOI] [PubMed] [Google Scholar]
- 2. ) Isoda , J. , Visakorpi , T. , Holli , K. and Kallioniemi , O. P.Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node‐negative breast cancer patients . J. Natl. Cancer Inst. , 84 , 1109 – 1114 ( 1992. ). [DOI] [PubMed] [Google Scholar]
- 3. ) Bosari , S. , Lee , A. K. C. , Viale , G. , Heatley , G. J. and Coggi , G.Abnormal p53 immunoreactivity and prognosis in node‐negative breast carcinomas with long‐term, follow‐up . Virchows Arch. A Pathol Anat. , 421 , 291 – 295 ( 1992. ). [DOI] [PubMed] [Google Scholar]
- 4. ) Barnes , D. M. , Dublin , E. A. , Fisher , C. J. , Levision , D. A. and Millis , R. R.Immunohistochemical detection of p53 protein in mammary carcinoma: an important new independent indicator of prognosis ? Hum. Pathol. , 24 , 469 – 476 ( 1993. ). [DOI] [PubMed] [Google Scholar]
- 5. ) Osborne , R. J. , Merlo , G. R. , Mitsudomi , T. , Venesio , T. , Liscia , D. S. , Cappa , A. P. M. , Chiba , I. , Takahashi , T. , Nau , M. M. , Callahan , R. and Minna , J. D.Mutations in the p53 gene in primary human breast cancers . Cancer Res. , 51 , 6194 – 6198 ( 1991. ). [PubMed] [Google Scholar]
- 6. ) Mazars , R. , Spinardi , L. , BenCheikh , M. , Simony‐Lafontaine , J. , Jeanteur , P. and Theillet , C.p53 mutations occur in aggressive breast cancer . Cancer Res. , 52 , 3918 – 3923 ( 1992. ). [PubMed] [Google Scholar]
- 7. ) Tsuda , H. , Iwaya , K. , Fukutomi , T. and Hirohashi , S.p53 mutations and c‐erbB‐2 amplification in intraductal and invasive breast carcinomas of high histologic grade . Jpn. J. Cancer Res. , 84 , 394 – 401 ( 1993. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. ) Sasa , M. , Kondo , K. , Komaki , K. , Uyama , T. , Morimoto , T. and Monden , Y.Frequency of spontaneous p53 mutations (CpG site) in breast cancer in Japan . Breast Cancer Res. Treat. , 27 , 247 – 252 ( 1993. ). [DOI] [PubMed] [Google Scholar]
- 9. ) Davidoff , A. M. , Kerns , B. J. , Iglehart , J. D. and Marks , J. R.Maintenance of p53 alterations throughout breast cancer progression . Cancer Res. , 51 , 2605 – 2610 ( 1991. ). [PubMed] [Google Scholar]
- 10. ) Davidoff , A. M. , Humphrey , P. A. , Iglehart , J. D. and Marks , J. R.Genetic basis for p53 overexpression in human breast cancer . Proc. Natl. Acad Sci. USA , 88 , 5006 – 5010 ( 1991. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. ) Runnebaum , I. B. , Nagarajan , M. , Bowman , M. , Soto , D. and Sukumar , S.Mutations in p53 as potential molecular markers for human breast cancer . Proc. Natl. Acad. Sci. USA , 88 , 10657 – 10661 ( 1991. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. ) Thompson , A. M. , Anderson , T. J. , Condie , A. , Prosser , J. , Chetty , U. , Carter , D. C. , Evans , H. J , and Steel , C. M.p53 allele losses, mutations and expression in breast cancer and their relationship to clinico‐pathological parameters . Int. J. Cancer , 50 , 528 – 532 ( 1992. ). [DOI] [PubMed] [Google Scholar]
- 13. ) World Health Organization . “Histological Typing of Breast Tumours,” 2nd Ed. , pp. 18 – 19 ( 1981. ). WHO; , Geneva . [Google Scholar]
- 14. ) Baak , J. P. A. , Dop , H. V. , Kurver , P. H. J. and Hermans , J.The value of morphometry to classic prognosticators in breast cancer . Cancer , 56 , 374 – 382 ( 1985. ). [DOI] [PubMed] [Google Scholar]
- 15. ) Bloom , H. G. J. and Richardson , W. W.Histologic grading and prognosis in breast cancer . Br. J. Cancer , 11 , 655 – 669 ( 1957. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. ) Lyons , J. , Landis , C. A. , Harsh , G. , Vallar , L. , Grunewald , K. , Feichtinger , H. , Ouan‐Yang , D. and Clark , O. H.Two G protein oncogenes in human endocrine tumors . Science , 249 , 655 – 659 ( 1990. ). [DOI] [PubMed] [Google Scholar]
- 17. ) Buchman , V. L. , Chumakov , P. M. , Ninkina , N. N. , Samarina , O. P. and Georgier , G. P.A variation in the structure of the protein‐coding region of the human p53 gene . Gene , 70 , 245 – 252 ( 1988. ). [DOI] [PubMed] [Google Scholar]
- 18. ) Midgley , C. A. , Fisher , C. J. , Bartek , J. , Vojtesek , B. , Lane , D. and Barnes , D. M.Analysis of p53 expression in human tumours: an antibody raised against human p53 expressed in Escherichia coli . J. Cell Sci. , 101 , 183 – 189 ( 1992. ). [DOI] [PubMed] [Google Scholar]
- 19. ) Esrig , D. , Spruck , C. H. , III , Nichols , P. W. , Chaiwun , B. , Steven , K. , Groshen , S. , Chen , S. C. , Skinner , D. G. , Jones , P. A. and Cote , R. J.p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer . Am. J. Pathol. , 143 , 1389 – 1397 ( 1993. ). [PMC free article] [PubMed] [Google Scholar]
- 20. ) Hollstein , M. , Sidransky , D. , Vogelstein , B. and Harris , C. C.p53 mutations in human cancers . Science , 253 , 49 – 53 ( 1991. ). [DOI] [PubMed] [Google Scholar]
- 21. ) Orita , M. , Suzuki , Y. , Sekiya , T. and Hayashi , K.Rapid and sensitive detection of point mutation and DNA polymorphisms using the polymerase chain reaction . Genomics , 5 , 874 – 879 ( 1989. ). [DOI] [PubMed] [Google Scholar]
- 22. ) Lehman , T. A. , Bennett , W. P. , Metcalf , R. A. , Welsh , J. A. , Ecker , J. , Modali , B. I. and Harris , C. C.p53 mutations, ras mutations, and p53 heat shock 70 protein complexes in human lung carcinoma cell lines . Cancer Res. , 51 , 4090 – 4096 ( 1991. ). [PubMed] [Google Scholar]
- 23. ) Tsuda , H. , Hirohashi , S. , Shimosato , Y. , Hirota , T. , Tsugane , S. , Watanabe , S. , Terada , M. and Yamamoto , H.Correlation between histologic grade of malignancy and copy number of c‐erbB‐2 gene in breast carcinoma , Cancer , 65 , 1794 – 1800 ( 1990. ). [DOI] [PubMed] [Google Scholar]